BRCA1 mutations in breast and ovarian cancer can predict treatment resistance

July 25, 2016, JCI Journals

Mutations in the BRCA1 gene are one of the most common risk factors for breast and ovarian cancers. Although tumors that harbor BRCA1 mutations initially respond well to cancer treatments, many tumors eventually become less responsive.

This month, two studies in the JCI investigated the mechanisms underlying the associated with some BRCA1 mutations, and the findings provide information that may help predict which treatments will be effective in women with breast and .

A team led by Jos Jonkers at the Netherlands Cancer Institute discovered that a mouse harboring an analog of the cancer-associated human BRCA1 mutation, BRCA1184delAG, expresses a BRCA1 protein that is missing a structural component called a RING domain. Loss of the RING domain predicted poor treatment responses in both mouse and human mammary tumors.

Neil Johnson's lab at the Fox Chase Cancer Center examined treatment resistance in expressing the same BRCA1185delAG mutation and determined that the RING-deficient BRCA1 protein was also responsible for loss of sensitivity to certain types of cancer treatments.

These findings identify specific BRCA1 mutations that are more likely to develop therapy resistance, which may lead to more accurate predictions and personalized treatments for breast and ovarian cancers.

Explore further: Research explains the role of the gene BRCA1 in DNA repair

More information: Rinske Drost et al, BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1, Journal of Clinical Investigation (2016). DOI: 10.1172/JCI70196

Yifan Wang et al. RING domain–deficient BRCA1 promotes PARP inhibitor and platinum resistance, Journal of Clinical Investigation (2016). DOI: 10.1172/JCI87033

Simon N. Powell. BRCA1 loses the ring but lords over resistance, Journal of Clinical Investigation (2016). DOI: 10.1172/JCI89209

Related Stories

Research explains the role of the gene BRCA1 in DNA repair

May 30, 2016
Scientists at the University of Birmingham are a step closer to understanding the role of the gene BRCA1. Changes in this gene are associated with a high risk of developing breast and ovarian cancer.

Uncovering a new principle in chemotherapy resistance in breast cancer

July 20, 2016
A laboratory study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes. The findings, ...

Women with BRCA1 gene mutation at higher risk of deadly uterine cancer

June 30, 2016
Women who carry the BRCA1 gene mutation that dramatically increases their risk of breast and ovarian cancers are also at higher risk for a lethal form of uterine cancer, according to a study led by a Duke Cancer Institute ...

New insights reported about the Angelina Jolie gene

March 4, 2016
Scientists from the Cancer Therapy & Research Center (CTRC) in San Antonio today (March 4) published work that provides deeper insight into how the Angelina Jolie gene, BRCA1, functions in normal breast tissue and how its ...

ADAMTS family of genes may be the next 'thing' in ovarian cancer treatment

June 11, 2015
There is the Addams Family. And then there is the ADAMTS family. While one is mindless entertainment, the latter may prove to be a new genetic avenue for designing ovarian cancer treatment.

Recommended for you

Scientists discover chemical which can kill glioblastoma cells

August 15, 2018
Aggressive brain tumour cells taken from patients self-destructed after being exposed to a chemical in laboratory tests, researchers have shown.

Three scientists share $500,000 prize for work on cancer therapy

August 15, 2018
Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a $500,000 medical ...

PARP inhibitor improves progression-free survival in patients with advanced breast cancers

August 15, 2018
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over ...

New clues into how 'trash bag of the cell' traps and seals off waste

August 15, 2018
The mechanics behind how an important process within the cell traps material before recycling it has puzzled scientists for years. But Penn State researchers have gained new insight into how this process seals off waste, ...

RUNX proteins act as regulators in DNA repair, study finds

August 15, 2018
A study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has revealed that RUNX proteins are integral to efficient DNA repair via the Fanconi Anemia (FA) ...

Chemicals found in vegetables prevent colon cancer in mice

August 14, 2018
Chemicals produced by vegetables such as kale, cabbage and broccoli could help to maintain a healthy gut and prevent colon cancer, a new study from the Francis Crick Institute shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.